Akciğer adenokarsinomlu vakalarda moleküler belirteçlerin radyolojik bulgularla korelasyonu
Ş Kaya - 2021 - gcris.pau.edu.tr
Amaç: Bu çalı? mada, kliniğimizde akciğer adenokarsinomu tanısı almı? hastalarda üç
moleküler belirteç (EGFR, ALK ve ROS1) sıklığını, moleküler belirteçler ile radyolojik …
moleküler belirteç (EGFR, ALK ve ROS1) sıklığını, moleküler belirteçler ile radyolojik …
Correlation between ALK, ROS1 Biomarkers and EGFR Oncogene Mutations in Lung Tumours: Our Observations in an Apex Oncopathology Laboratory
RR Kishore, V Pan - Asian Pacific Journal of Cancer Biology, 2023 - waocp.com
Abstract Introduction: Analysis of Anaplastic lymphoma receptor tyrosine kinase gene (ALK),
Repressor of Silencing 1 (ROS1) gene are determined by immunohistochemistry (IHC) and …
Repressor of Silencing 1 (ROS1) gene are determined by immunohistochemistry (IHC) and …
Analysis of relationship between gene status (EGFR, ALK, ROS1) and clinicopathological features in 1 232 cases of lung adenocarcinoma with lesion of maximum …
ZHU Xia, W Xin, JIN Jingjing, X Li - Journal of Diagnostics Concepts & …, 2024 - qk.sjtu.edu.cn
Objective To study relationship between gene status [epidermal growth factor receptor
(EGFR), anaplastic lymphoma kinase (ALK) and ROS proto-oncogene 1, receptor tyrosine …
(EGFR), anaplastic lymphoma kinase (ALK) and ROS proto-oncogene 1, receptor tyrosine …
Analysis of multigene detection in patients with advanced lung adenocarcinoma using cytological specimens
Y Ma, Y Du, R Wang, X Ji, J Wu, Y Liu, X Guo… - … -Research and Practice, 2020 - Elsevier
Objective To investigate the mutation status and clinical characteristics of multigene
detection in advanced lung adenocarcinoma using cytological specimens. Materials and …
detection in advanced lung adenocarcinoma using cytological specimens. Materials and …
EP03. 01-005 Clinicopathological Features of ROS1-rearranged Adenocarcinomas: A Single Institutional Experience Spanning Four Years From India
Methods Study was of combined retrospective (2018-2019) and prospective (2020-2021)
design. All patients presenting with advanced stage non-squamous non-small cell lung …
design. All patients presenting with advanced stage non-squamous non-small cell lung …
EGFR mutasyonu bulunduran ve bulundurmayan akciğer karsinoması olgularında morfolojik ve immünhistokimyasal özellikler
M Musayeva - dspace.ankara.edu.tr
Amaç: Akciğer adenokarsinomasında Epidermal Büyüme Faktörü Reseptörü (EGFR)
mutasyonları sık görülen bir bulgudur ve bu mutasyonları bulunduran olgularda EGFR …
mutasyonları sık görülen bir bulgudur ve bu mutasyonları bulunduran olgularda EGFR …
PCR-based detection of EGFR, ALK, KRAS and BRAF mutations in Russian patients with lung adenocarcinoma: a single-center experience.
NV Mitiushkina, MM Kholmatov, AR Venina, VI Tiurin… - Neoplasma, 2018 - europepmc.org
In contrast to other countries with predominantly white populations, Russian smoking-related
lung cancers (LC) are mainly squamous cell carcinomas and approximately half lung …
lung cancers (LC) are mainly squamous cell carcinomas and approximately half lung …
Value of CT features for predicting EGFR mutations and ALK positivity in patients with lung adenocarcinoma
X Han, J Fan, Y Li, Y Cao, J Gu, X Jia, Y Wang, H Shi - Scientific reports, 2021 - nature.com
The aim of this study was to identify the relationships of epidermal growth factor receptor
(EGFR) mutations and anaplastic large-cell lymphoma kinase (ALK) status with CT …
(EGFR) mutations and anaplastic large-cell lymphoma kinase (ALK) status with CT …
NADİR GÖRÜLEN EXON 18 (G719A) VE EXON 20 (S768I) MUTASYONU İLE İZLENEN AKCİĞER ADENOKANSERİ; VAKA TAKDİMİ
B Kanbur, M Kılınç, R Kantar, M Uzun, İ Ünek - 2022 - avesis.deu.edu.tr
Giriş: Akciğer kanseri dünya çapında en yaygın kanserlerden biridir. Adenokarsinom,
çağdaş serilerdeki en yaygın akciğer kanseri türüdür ve akciğer kanseri vakalarının yaklaşık …
çağdaş serilerdeki en yaygın akciğer kanseri türüdür ve akciğer kanseri vakalarının yaklaşık …
Relationship between EGFR, ALK Gene Mutation and Imaging and Pathological Features in Invasive Lung Adenocarcinoma.
Y He, LIU Zicheng, W Hongya, C Liang… - Chinese Journal of …, 2022 - search.ebscohost.com
Background and objective At present, the research progress of targeted therapy for
epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) gene …
epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) gene …